Nov-02-20 Upgrade
Barclays
Equal Weight → Overweight
$166
Aug-04-20 Upgrade
Deutsche Bank
Hold → Buy
$202
May-22-20 Upgrade
Wolfe Research
Peer Perform → Outperform
May-15-20 Upgrade
UBS
Neutral → Buy
$151 → $160
Apr-23-20 Resumed
Credit Suisse
Neutral
$146
Mar-18-20 Upgrade
Goldman
Neutral → Buy
$173 → $174
Mar-13-20 Upgrade
Guggenheim
Neutral → Buy
Feb-07-20 Upgrade
Robert W. Baird
Neutral → Outperform
$197
Jan-10-20 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$162
Sep-12-19 Initiated
Deutsche Bank
Hold
Aug-05-19 Downgrade
Wolfe Research
Outperform → Peer Perform
Jul-22-19 Initiated
Guggenheim
Neutral
$152
Jan-17-19 Initiated
UBS
Neutral
$134
Oct-26-18 Reiterated
Barclays
Equal Weight
$150 → $136
Jul-20-18 Downgrade
Robert W. Baird
Outperform → Neutral
May-29-18 Reiterated
Leerink Partners
Mkt Perform
$170 → $160
Mar-08-18 Initiated
Barclays
Equal Weight
$165
Feb-27-18 Resumed
BofA/Merrill
Buy
Feb-02-18 Reiterated
Mizuho
Neutral
$186 → $179
Jan-24-18 Upgrade
Jefferies
Hold → Buy
Jan-22-21 08:00AM
Jan-21-21 03:39PM
Jan-20-21 02:46PM
Jan-15-21 12:10PM
Jan-14-21 08:15AM
07:20AM
Jan-13-21 11:15AM
09:45AM
09:32AM
Jan-12-21 11:41AM
11:10AM
Jan-11-21 09:48AM
08:56AM
03:38AM
Jan-08-21 09:47AM
Jan-05-21 12:18PM
Jan-04-21 09:26AM
Jan-01-21 11:50AM
Dec-30-20 11:40AM
Dec-29-20 08:00AM
Dec-28-20 04:10PM
12:18PM
08:54AM
Dec-27-20 12:10PM
Dec-24-20 02:47PM
10:00AM
Dec-23-20 01:45PM
06:54AM
Dec-22-20 04:15PM Investor's Business Daily
Dec-21-20 04:41PM
Dec-19-20 07:00AM
Dec-18-20 05:17PM
12:44PM
Dec-16-20 11:50AM
Dec-14-20 11:40AM
10:57AM
07:00AM
Dec-11-20 08:20AM
Dec-09-20 09:40AM
Dec-08-20 07:03AM
Dec-07-20 06:13PM
12:22PM
Dec-03-20 11:30AM
Nov-30-20 01:46PM
08:54AM
Nov-25-20 01:36AM
Nov-24-20 01:35PM
Nov-23-20 11:38AM
07:33AM
Nov-19-20 06:33PM Investor's Business Daily
04:15PM
01:48PM
Nov-18-20 09:12AM
09:06AM
Nov-17-20 10:35AM
10:04AM
Nov-12-20 09:33AM
Nov-06-20 07:51AM
Nov-05-20 08:55AM
Nov-04-20 09:32AM
04:25AM
Nov-03-20 04:17PM Investor's Business Daily +5.25%
01:31PM
10:19AM
09:30AM
09:28AM
08:50AM
08:25AM
07:30AM
07:00AM
Nov-02-20 03:00AM
Oct-30-20 11:15AM
Oct-29-20 04:10PM
07:53AM
Oct-22-20 02:04PM
Oct-19-20 07:00AM
Oct-12-20 11:40AM
Oct-05-20 04:10PM
12:16PM
Oct-02-20 11:52AM
Sep-25-20 10:00AM Investor's Business Daily
Sep-24-20 10:55AM
Sep-16-20 12:57PM
09:16AM
Sep-15-20 08:00PM
08:00PM
Sep-03-20 04:12PM Investor's Business Daily
Sep-02-20 11:30AM
Sep-01-20 03:06AM
Aug-28-20 04:54PM
01:13PM
Aug-26-20 08:05AM
Aug-24-20 01:02PM
Aug-22-20 11:40AM
Aug-19-20 02:28AM
Aug-18-20 11:08AM
10:39AM
10:20AM
09:54AM
09:51AM
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions, International, and Medical-Surgical Solutions. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and solutions for life sciences companies, including offering multiple distribution channels and clinical trial access to specific patient populations through its network of oncology physicians. The segment also sells financial, operational and clinical solutions to pharmacies; and offers consulting, outsourcing, and other services. The Prescription Technology Solutions segment operates in the healthcare delivery system to connect pharmacies, providers, payers, and biopharma for next-generation patient access and adherence solutions. The International segment provides drug distribution services, specialty pharmacy, and retail and infusion care services. The Medical-Surgical Solutions segment distributes medical-surgical supplies and provides logistics and other services to healthcare providers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
TYLER BRIAN S. Chief Executive Officer Jan 15 Option Exercise 183.37 5,510 1,010,369 24,500 Jan 20 05:34 PM Vitalone Britt J. EVP & CFO Jan 15 Option Exercise 159.00 4,339 689,901 5,390 Jan 20 05:37 PM Reddy Sundeep G. SVP & Controller Jan 15 Sale 182.32 450 82,044 1,534 Jan 20 05:36 PM TYLER BRIAN S. Chief Executive Officer Jan 15 Sale 184.32 5,510 1,015,624 18,990 Jan 20 05:34 PM Vitalone Britt J. EVP & CFO Jan 15 Sale 185.00 9,057 1,675,545 1,051 Jan 20 05:37 PM Faber Tracy EVP & Chief HR Officer Dec 15 Sale 174.00 546 95,004 2,101 Dec 16 07:08 PM Faber Tracy EVP & Chief HR Officer Nov 04 Option Exercise 0.00 901 0 2,710 Nov 06 05:27 PM Vitalone Britt J. EVP & CFO Nov 04 Option Exercise 144.43 6,324 913,375 12,090 Nov 05 05:18 PM Vitalone Britt J. EVP & CFO Nov 04 Sale 165.00 6,324 1,043,460 5,766 Nov 05 05:18 PM Vitalone Britt J. EVP & CFO Nov 03 Option Exercise 0.00 8,181 0 9,229 Nov 05 05:18 PM Jacobs Christine M Director Nov 03 Sale 160.00 1,157 185,120 0 Nov 04 12:09 PM COLES N ANTHONY Director Aug 17 Sale 156.77 2,453 384,559 0 Aug 19 03:35 PM KNOWLES MARIE L/CA Director Aug 07 Sale 150.83 1,157 174,510 0 Aug 10 05:39 PM Vitalone Britt J. EVP & CFO Jun 02 Option Exercise 144.43 6,324 913,375 7,372 Jun 04 02:54 PM Vitalone Britt J. EVP & CFO Jun 02 Sale 158.90 6,324 1,004,909 1,048 Jun 04 02:54 PM Schechter Lori A. EVP, Chief Legal Officer & GC Jun 01 Option Exercise 144.43 5,488 792,632 11,397 Jun 02 07:04 PM Schechter Lori A. EVP, Chief Legal Officer & GC Jun 01 Sale 160.00 5,488 878,080 5,909 Jun 02 07:04 PM Faber Tracy EVP & Chief HR Officer May 30 Option Exercise 0.00 1,154 0 2,090 Jun 02 07:03 PM Reddy Sundeep G. SVP & Controller May 30 Option Exercise 0.00 231 0 2,153 Jun 02 07:03 PM Vitalone Britt J. EVP & CFO May 27 Sale 149.60 1,034 154,686 1,048 May 28 06:53 PM Reddy Sundeep G. SVP & Controller May 27 Sale 149.60 92 13,763 1,922 May 28 06:50 PM Reddy Sundeep G. SVP & Controller May 26 Sale 152.45 59 8,995 1,955 May 26 08:12 PM Faber Tracy EVP & Chief HR Officer May 23 Option Exercise 0.00 854 0 1,154 May 26 08:14 PM Reddy Sundeep G. SVP & Controller May 23 Option Exercise 0.00 524 0 2,172 May 26 08:12 PM Vitalone Britt J. EVP & CFO May 23 Option Exercise 0.00 1,367 0 2,415 May 26 08:15 PM Vitalone Britt J. EVP & CFO May 22 Sale 145.91 2,358 344,056 1,048 May 26 08:15 PM Vitalone Britt J. EVP & CFO May 21 Option Exercise 0.00 3,117 0 4,165 May 26 08:15 PM Reddy Sundeep G. SVP & Controller May 21 Option Exercise 0.00 338 0 1,750 May 26 08:12 PM Schechter Lori A. EVP, Chief Legal Officer & GC May 21 Option Exercise 0.00 2,706 0 2,706 May 26 08:11 PM Faber Tracy EVP & Chief HR Officer May 21 Option Exercise 0.00 384 0 384 May 26 08:14 PM TYLER BRIAN S. Chief Executive Officer May 21 Option Exercise 0.00 10,260 0 22,452 May 26 08:13 PM Reddy Sundeep G. SVP & Controller May 12 Sale 141.18 61 8,612 1,412 May 13 03:42 PM Reddy Sundeep G. SVP & Controller May 09 Option Exercise 0.00 349 0 1,580 May 12 07:02 PM TYLER BRIAN S. Chief Executive Officer Apr 15 Option Exercise 118.41 4,063 481,100 16,255 Apr 17 12:10 PM TYLER BRIAN S. Chief Executive Officer Apr 15 Sale 135.00 4,063 548,517 12,192 Apr 17 12:10 PM TYLER BRIAN S. Chief Executive Officer Mar 16 Option Exercise 118.41 4,063 481,100 16,255 Mar 18 03:14 PM TYLER BRIAN S. Chief Executive Officer Mar 16 Sale 124.77 4,063 506,940 12,192 Mar 18 03:14 PM TYLER BRIAN S. Chief Executive Officer Feb 14 Option Exercise 118.41 4,062 480,981 16,254 Feb 19 02:21 PM TYLER BRIAN S. Chief Executive Officer Feb 14 Sale 167.09 4,062 678,720 12,192 Feb 19 02:21 PM Schechter Lori A. EVP, CLO & GC Feb 11 Option Exercise 144.43 5,487 792,487 5,669 Feb 13 04:00 PM Schechter Lori A. EVP, CLO & GC Feb 11 Sale 162.34 5,487 890,760 182 Feb 13 04:00 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite